Results 281 to 290 of about 9,130,139 (414)

Advancements in surgical treatments for Huntington disease: From pallidotomy to experimental therapies. [PDF]

Neurotherapeutics
Kim LJY, Kundu B, Moretti P, Lozano AM, Rahimpour S.   +4 more
europepmc   +1 more source

Pitfalls in the Use of Voxel-Based Morphometry as a Biomarker: Examples from Huntington Disease [PDF]

, 2009
Susie M.D. Henley, Gerard R. Ridgway, Rachael I. Scahill, Stefan Klöppel, Sarah J. Tabrizi, Nick C. Fox, Jan Kassubek   +6 more
openalex   +1 more source

Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease

Neuron, 2019
S. Tabrizi, R. Ghosh, B. Leavitt
semanticscholar   +1 more source

Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis

Brain Pathology, EarlyView.
We have sought to determine the role that cholesterol metabolism plays in disability worsening and its correlation with progressive MS by analysing patient CSF and post‐mortem tissues using cutting edge mass spectrometry approaches. Key sterol metabolites measured in the CSF link with important disability milestones at the very early stages of MS ...
Lauren Griffiths, Kristen Hawkins, Eylan Yutuc, Roberto Angelini, Racheal Fosuah, Manuela Pacciarini, Alison Dickson, Neil Robertson, Laura Childs, Samantha Loveless, Emma Tallantyre, William J. Griffiths, Yuqin Wang, Owain W. Howell   +13 more
wiley   +1 more source

Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST-JHD Study. [PDF]

Mov Disord Clin Pract
Caligiuri ME, Tinelli E, Vizza P, Giancaterino G, Cicone F, Cascini GL, Sabatini U, Squitieri F.   +7 more
europepmc   +1 more source

Health Services in Huntington Disease: A Systematic Literature Review. [PDF]

Neurol Clin Pract, 2023
Mendizabal A, Diaz JM, Bustamante AV, Bordelon Y.   +3 more
europepmc   +1 more source

Dietary intake in adults at risk for Huntington disease [PDF]

, 2009
Karen Marder, Hongwei Zhao, Shirley Eberly, Caroline M. Tanner, David Oakes, Ira Shoulson   +5 more
openalex   +1 more source

ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system

British Journal of Pharmacology, EarlyView.
G protein‐coupled receptors (GPCRs) are a large family of cell surface receptors that play a critical role in nervous system function by transmitting signals between cells and their environment. They are involved in many, if not all, nervous system processes, and their dysfunction has been linked to various neurological disorders representing important
Necla Birgül Iyison, Clauda Abboud, Dayana Abboud, Abdulrasheed O. Abdulrahman, Ana‐Nicoleta Bondar, Julie Dam, Zafiroula Georgoussi, Jesús Giraldo, Anemari Horvat, Christos Karoussiotis, Alba Paz‐Castro, Miriam Scarpa, Hannes Schihada, Nicole Scholz, Bilge Güvenc Tuna, Nina Vardjan   +15 more
wiley   +1 more source

Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective. [PDF]

Neurol Ther
Pérez-Pérez J, García-López S, Valle TF, Painous C, Querol-Pascual MR, Ruiz PJG, Diago EB, Cubo Delgado E, Pastor BV, Villaplana MCP, Santana IM, Blázquez Estrada M, Garride MC, Mir P, Álvarez C, Maurino J, de Prado A, López-Sendón JL.   +17 more
europepmc   +1 more source

Targeting the autophagy-lysosomal pathway in Huntington disease: a pharmacological perspective. [PDF]

Front Aging Neurosci, 2023
Yang J, Zhang C.
europepmc   +1 more source